טוען...
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
With advancements in gene editing technologies, our ability to make precise and efficient modifications to the genome is increasing at a remarkable rate, paving the way for scientists and clinicians to uniquely treat a multitude of previously irremediable diseases. CRISPR-Cas9, short for clustered r...
שמור ב:
| הוצא לאור ב: | J Biomed Res |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Editorial Department of Journal of Biomedical Research
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8038529/ https://ncbi.nlm.nih.gov/pubmed/33349624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.34.20200096 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|